Dr Reddy’s Q3 net profit up 77 pc at Rs 1,247 cr
Jan 25, 2023, at 11:39 pm
Hyderabad: Generic Drug maker, Dr Reddy’s Laboratories’ on Wednesday reported a 77 per cent increase in consolidated net profit to Rs 1,247 crore in the third quarter ended December 2022 as against Rs 706 crore in the corresponding quarter in the previous year.
Dr Reddy Lab down 10.44 pc to Rs 4844.35
Jul 27, 2021, at 11:01 pm
Mumbai/UNI: Dr Reddy Lab on Tuesday dropped by 10.44 pc to Rs 4844.35, a major loser in 30 scrips of BSE.
Dr Reddy's Labs gets Emergency Use authorisation for Sputnik V in India
Apr 13, 2021, at 07:34 pm
Mumbai/UNI: Pharma major Dr Reddy's Laboratories on Tuesday said that it has received the permission from the Drug Controller General of India (DCGI) to import the Sputnik vaccine into India for restricted use in emergency situations.
Dr Reddy's Laboratories to launch Testosterone Gel
May 06, 2019, at 05:45 pm
Mumbai, May 6 (UNI) Pharma Major, Dr Reddy's Laboratories Ltd on Monday announced the launch of Testosterone Gel 1.62 pc, a therapeutic equivalent generic version of AndroGel (testosterone gel) 1.62 pc, approved by the US Food and Drug Administration (USFDA).